Naproxen and Carcinoembryonic antigen increased - a phase IV clinical study of FDA data

Summary:

Carcinoembryonic antigen increased is reported as a side effect among people who take Naproxen (naproxen), especially for people who are female, 50-59 old, also take Compazine, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Carcinoembryonic antigen increased when taking Naproxen. It is created by eHealthMe based on reports of 68,942 people who have side effects when taking Naproxen from the FDA, and is updated regularly.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,034 Naproxen users. Check the latest studies of Naproxen.

What is Carcinoembryonic antigen increased?

Carcinoembryonic antigen increased is found to be associated with 252 drugs and 331 conditions by eHealthMe. Check the latest studies of Carcinoembryonic antigen increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

68,942 people reported to have side effects when taking Naproxen.
Among them, 14 people (0.02%) have Carcinoembryonic antigen increased.

Could Naproxen cause Carcinoembryonic antigen increased?

Among these 14 people:

What is the gender of people who have Carcinoembryonic antigen increased when taking Naproxen? *

female: 92.86 %
male: 7.14 %

What is the age of people who have Carcinoembryonic antigen increased when taking Naproxen? *

What are other drugs people take besides Naproxen? *

What are other side effects people have besides Carcinoembryonic antigen increased? *

Intervertebral Disc Protrusion (spinal disc protrusion): 13 people, 92.86%
Gallstones (stone formation by bile component): 13 people, 92.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 92.86%
Gingivitis (inflammation of gums): 13 people, 92.86%
Anogenital Warts: 13 people, 92.86%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 13 people, 92.86%
Hypertriglyceridaemia (excess of triglycerides in the blood): 13 people, 92.86%
Impaired Healing: 13 people, 92.86%
Ingrowing Nail: 13 people, 92.86%
Injury: 13 people, 92.86%

What are the existing conditions these people have? *

Stress And Anxiety: 13 people, 92.86%
Breast Cancer Metastatic: 7 people, 50.00%
Joint Pain: 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.14%
Breast Cancer: 1 person, 7.14%
Blood Pressure Abnormal: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and have Carcinoembryonic antigen increased?

- Check whether Carcinoembryonic antigen increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naproxen:

Naproxen (72,034 reports)

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Carcinoembryonic antigen increased:

Carcinoembryonic antigen increased (252 drugs)

Browse all the conditions that are associated with Carcinoembryonic antigen increased:

Carcinoembryonic antigen increased (331 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen (the active ingredients of Naproxen) and Naproxen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.